Population Pharmacokinetic Analysis of Lanreotide Autogel/Depot in the Treatment of Neuroendocrine Tumors: Pooled Analysis of Four Clinical Trials.
about
Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors.Optimal dynamic control approach in a multi-objective therapeutic scenario: Application to drug delivery in the treatment of prostate cancer.
P2860
Population Pharmacokinetic Analysis of Lanreotide Autogel/Depot in the Treatment of Neuroendocrine Tumors: Pooled Analysis of Four Clinical Trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Population Pharmacokinetic Ana ...... lysis of Four Clinical Trials.
@en
type
label
Population Pharmacokinetic Ana ...... lysis of Four Clinical Trials.
@en
prefLabel
Population Pharmacokinetic Ana ...... lysis of Four Clinical Trials.
@en
P2093
P2860
P1476
Population Pharmacokinetic Ana ...... lysis of Four Clinical Trials.
@en
P2093
Amandine Manon
Edda L Gomez-Panzani
Marion Dehez
Núria Buil-Bruna
Thi Xuan Quyen Nguyen
P2860
P2888
P304
P356
10.1007/S40262-015-0329-4
P577
2015-09-28T00:00:00Z
P6179
1032721360